Schonfeld Strategic Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,192
| Closed | -$40.1K | – | 1856 |
|
|
2024
Q2 | $40.1K | Buy |
+17,192
| New | +$40.1K | ﹤0.01% | 1816 |
|
|
2024
Q1 | – | Sell |
-35,300
| Closed | -$113K | – | 1847 |
|
|
2023
Q4 | $113K | Buy |
+35,300
| New | +$113K | ﹤0.01% | 1518 |
|
|
2023
Q3 | – | Sell |
-102,285
| Closed | -$508K | – | 1598 |
|
|
2023
Q2 | $508K | Buy |
+102,285
| New | +$508K | ﹤0.01% | 1189 |
|
|
2023
Q1 | – | Sell |
-124,500
| Closed | -$783K | – | 1978 |
|
|
2022
Q4 | $783K | Sell |
124,500
-139,391
| -53% | -$877K | 0.01% | 1270 |
|
|
2022
Q3 | $2.85M | Buy |
263,891
+145,491
| +123% | +$1.57M | 0.02% | 728 |
|
|
2022
Q2 | $1.35M | Buy |
118,400
+38,000
| +47% | +$433K | 0.01% | 819 |
|
|
2022
Q1 | $732K | Buy |
+80,400
| New | +$732K | 0.01% | 1087 |
|
|
2021
Q4 | – | Sell |
-40,500
| Closed | -$1.04M | – | 1940 |
|
|
2021
Q3 | $1.04M | Sell |
40,500
-63,779
| -61% | -$1.64M | 0.01% | 865 |
|
|
2021
Q2 | $2.72M | Buy |
+104,279
| New | +$2.72M | 0.03% | 593 |
|
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$269K | – | 1015 |
|
|
2018
Q4 | $269K | Buy |
+10,000
| New | +$269K | 0.01% | 857 |
|